Your browser doesn't support javascript.
loading
Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI.
Yoshida, Kotaro; Kawashima, Hiroko; Kannon, Takayuki; Tajima, Atsushi; Ohno, Naoki; Terada, Kanako; Takamatsu, Atsushi; Adachi, Hayato; Ohno, Masako; Miyati, Tosiaki; Ishikawa, Satoko; Ikeda, Hiroko; Gabata, Toshifumi.
Affiliation
  • Yoshida K; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: kotaro_yoshida@staff.kanazawa-u.ac.jp.
  • Kawashima H; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: hirokok@med.kanazawa-u.ac.jp.
  • Kannon T; Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: kannon@med.kanazawa-u.ac.jp.
  • Tajima A; Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: atajima@med.kanazawa-u.ac.jp.
  • Ohno N; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: nohno@med.kanazawa-u.ac.jp.
  • Terada K; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.
  • Takamatsu A; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.
  • Adachi H; Division of Radiology, Kanazawa University Hospital, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.
  • Ohno M; Division of Radiology, Kanazawa University Hospital, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: takanaga@med.kanazawa-u.ac.jp.
  • Miyati T; Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: ramiyati@mhs.mp.kanazawa-u.ac.jp.
  • Ishikawa S; Department of Breast Surgery, Kanazawa University Hospital, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: s.ishikawa55@staff.kanazawa-u.ac.jp.
  • Ikeda H; Diagnostic Pathology, Kanazawa University Hospital, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: h-ikeda@med.kanazawa-u.ac.jp.
  • Gabata T; Department of Radiology, Kanazawa University Graduate School of Medical Sciences, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan. Electronic address: gabata@med.kanazawa-u.ac.jp.
Magn Reson Imaging ; 92: 19-25, 2022 10.
Article in En | MEDLINE | ID: mdl-35636571
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Magn Reson Imaging Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans Language: En Journal: Magn Reson Imaging Year: 2022 Document type: Article